241 related articles for article (PubMed ID: 10072560)
21. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
22. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA.
Osman Y; Narita M; Ayres F; Takahashi M; Alldawi L; Tatsuo F; Toba K; Hirohashi T; Aizawa Y
Cytotherapy; 2003; 5(2):161-8. PubMed ID: 12745578
[TBL] [Abstract][Full Text] [Related]
23. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism.
Liu AY; Miskovsky EP; Stanhope PE; Siliciano RF
J Immunol; 1992 Jun; 148(12):3789-98. PubMed ID: 1351088
[TBL] [Abstract][Full Text] [Related]
24. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM
Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560
[TBL] [Abstract][Full Text] [Related]
25. Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Nef-expressing DNA vaccine.
Asakura Y; Hamajima K; Fukushima J; Mohri H; Okubo T; Okuda K
Am J Hematol; 1996 Oct; 53(2):116-7. PubMed ID: 8892736
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.
Haas G; Plikat U; Debré P; Lucchiari M; Katlama C; Dudoit Y; Bonduelle O; Bauer M; Ihlenfeldt HG; Jung G; Maier B; Meyerhans A; Autran B
J Immunol; 1996 Nov; 157(9):4212-21. PubMed ID: 8892659
[TBL] [Abstract][Full Text] [Related]
27. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
28. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
[TBL] [Abstract][Full Text] [Related]
29. Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression.
Ali A; Ng HL; Dagarag MD; Yang OO
Eur J Immunol; 2005 Nov; 35(11):3221-8. PubMed ID: 16206233
[TBL] [Abstract][Full Text] [Related]
30. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
[TBL] [Abstract][Full Text] [Related]
31. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70.
Peng M; Chen M; Ling N; Xu H; Qing Y; Ren H
Vaccine; 2006 Feb; 24(7):887-96. PubMed ID: 16446013
[TBL] [Abstract][Full Text] [Related]
32. Generation of antigen-specific CD8+ CTLs from naive precursors.
Mehta-Damani A; Markowicz S; Engleman EG
J Immunol; 1994 Aug; 153(3):996-1003. PubMed ID: 8027569
[TBL] [Abstract][Full Text] [Related]
33. Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide.
Kim DT; Mitchell DJ; Brockstedt DG; Fong L; Nolan GP; Fathman CG; Engleman EG; Rothbard JB
J Immunol; 1997 Aug; 159(4):1666-8. PubMed ID: 9257826
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 Nef equips dendritic cells to reduce survival and function of CD8+ T cells: a mechanism of immune evasion.
Quaranta MG; Mattioli B; Giordani L; Viora M
FASEB J; 2004 Sep; 18(12):1459-61. PubMed ID: 15240562
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cytotoxic T cell responses to candidate HIV-1 vaccines in HIV-1-uninfected individuals.
McElrath MJ; Corey L; Greenberg PD
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S69-72. PubMed ID: 7865336
[TBL] [Abstract][Full Text] [Related]
36. Cutting edge: induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen.
Tobery T; Siliciano RF
J Immunol; 1999 Jan; 162(2):639-42. PubMed ID: 9916680
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Nef-induced CD4 T cell proliferation.
Torres BA; Tanabe T; Johnson HM
Biochem Biophys Res Commun; 1996 Aug; 225(1):54-61. PubMed ID: 8769094
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
Langlade-Demoyen P; Ngo-Giang-Huong N; Ferchal F; Oksenhendler E
J Clin Invest; 1994 Mar; 93(3):1293-7. PubMed ID: 8132769
[TBL] [Abstract][Full Text] [Related]
39. CD8+ cytolytic T lymphocytes become infected in vitro in the process of killing HIV-1-infected target cells.
De Maria A; Colombini S; Schnittman SM; Moretta L
Eur J Immunol; 1994 Mar; 24(3):531-6. PubMed ID: 7907291
[TBL] [Abstract][Full Text] [Related]
40. Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
Kent SJ; Greenberg PD; Hoffman MC; Akridge RE; McElrath MJ
J Immunol; 1997 Jan; 158(2):807-15. PubMed ID: 8992998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
